Highnoon Laboratories, Beximco Pharmaceuticals partner to help transform healthcare in Pakistan
Both companies are listed on the stock exchanges in their respective countries.
The memorandum of understanding (MoU) was signed at Beximco's headquarters in Dhaka by Dr Adeel Abbas, Co-Chairman & CEO of Highnoon Laboratories Limited, and Mr Rabbur Reza, Chief Operating Officer of Beximco Pharmaceuticals Limited.
The partnership will focus on the distribution, marketing, and sales of specialiased pharmaceutical products in Pakistan, with an emphasis on respiratory, diabetes, and cardiovascular therapeutic segments.
The collaboration is designed to strengthen Highnoon's portfolio in these high-impact areas, providing a competitive edge through innovative drug delivery systems and clinical advancements, according to the company.
Highnoon is listed on the Pakistan Stock Exchange. With cGMP- compliant manufacturing capabilities and a diverse product portfolio across major therapeutic areas, the company continues to position itself as a trusted healthcare partner, both locally and internationally.
The collaboration also reflects the strengthening economic ties between Pakistan and Bangladesh, reinforcing a shared vision for regional cooperation in healthcare and trade.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Express Tribune
41 minutes ago
- Express Tribune
Pakistan, KSA ink $121m deals for health, energy projects
Saudi Ambassador Nawaf bin Said Al-Malki on Friday reaffirmed Riyadh's unwavering support for Pakistan's development journey. Speaking at a ceremony marking the signing of consulting services contracts to support development projects in Pakistan - financed by the Saudi Fund for Development (SFD) - Al-Malki said the projects would provide vital services, boost economic growth, and contribute to the well-being of the Pakistani people. The Saudi Fund for Development (SFD) has signed consultancy service contracts for three major projects in Pakistan — the King Salman Hospital in Tarlai and the Shounter and Jagran hydropower projects in Azad Jammu & Kashmir — with a combined financing package worth $121 million. The King Salman Hospital will be funded through a $20 million grant from the Kingdom of Saudi Arabia, while the Shounter and Jagran hydropower projects will receive concessional loans of $66 million and $35 million respectively.
Express Tribune
6 hours ago
- Express Tribune
Oman opens fully funded scholarships for Pakistani students
Applicants must be Pakistani, aged 23 or under, Grade 12 qualified in past 3 years, and medically fit. PHOTO: PIXABAY Oman has opened applications for fully funded undergraduate scholarships under the Omani Programme for Cultural and Scientific Cooperation, giving international students — including Pakistani nationals — the opportunity to study for bachelor's degrees in selected fields. According to Gulf News, the awards cover courses in engineering, humanities, information technology and sciences (excluding medicine) at leading private higher education institutions across Oman. Scholarship benefits include: Full waiver of tuition fees Monthly stipend of OMR 200 if accommodation is not provided, or OMR 140 with free housing One round-trip air ticket per academic year Option to select up to three universities and two academic majors Eligibility requirements stipulate that applicants must be Pakistani nationals aged 23 or under, hold an intermediate or equivalent qualification (Grade 12) completed within the past three years, and be medically fit. An Equivalency Certificate from Oman's Ministry of Education is also required. Required documentation includes a valid passport, academic certificates, the Omani equivalency certificate, and — where available — proof of English language proficiency. All documents must be submitted in English, comply with file size limits (2MB for PDFs, 1MB for images), and avoid special characters in filenames. Application process: Candidates must apply directly to Omani universities by August 25, 2025 and send their details to the Embassy of Pakistan in Muscat at parepmuscat@ Online registration is also required via the Ministry's portal:
Business Recorder
8 hours ago
- Business Recorder
CCP's order against GCC Medical Centres upheld
The Competition Appellate Tribunal (CAT) upheld the Competition Commission of Pakistan's (CCP) order against 20 medical centers and laboratories and their five associations for collusive price fixing, territorial allocation of customers, and other anti-competitive practices in mandatory pre-departure medical examinations for Pakistani workers bound for Gulf countries, according to a CCP statement on Friday. The tribunal upheld CCP's findings of competition law violations but reduced the penalties from Rs20 million per medical center and Rs10 million per GAMCA to Rs2 million per center and Rs1 million per GAMCA. CCP 2019 order: Appellate Tribunal grants partial relief to flour mills, upholds Rs35mn fine The case concerns a captive market of low-income Pakistani laborers — many securing manual jobs in Saudi Arabia, Qatar, Oman, Bahrain, and Kuwait — who must undergo medical tests at GCC-approved centers before departure. The CCP's inquiry found that GAMCAs in five regions — Islamabad/Rawalpindi, Lahore, Peshawar, Karachi, and Multan — allocated customers on a rotational basis. 'This eliminated competition on price and service quality. Workers were bound to a specific center, charged a uniform fee, and in some cases subjected to unnecessary repeat tests for additional payments.' The CCP initiated its inquiry on a complaint by the Pakistan Overseas Employment Promoters Association (POEPA). The CCP's investigation concluded that fee fixation, territorial division, and equal allocation of customers by GAMCAs violated Sections 4 of the Competition Act, 2010. Dr Kabir Sidhu, Chairman CCP, warned business associations against facilitating collusive practices, price fixing, or allocation of business quotas. He stressed that such platforms should be used to promote sectoral growth, enhancing competition, and to benefit consumers. Any anti-competitive conduct will be dealt with strictly under the competition law.
